Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Vestergaard

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Trials|March 1, 2017
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registriesLouise A A Gerbens, Aaron E Boyce, Dmitri Wall, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 6, 2023
A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head-and-neck dermatitisIda Vittrup, Niels Steen Krogh, Henrik Hedegaard Pliess Larsen, et al.
Acta Dermato-Venereologica|September 14, 2020
Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi ProcessJacob P Thyssen, Steffen Heegaard, Lena Ivert, et al.
Dermatology (Basel, Switzerland)|September 13, 2025
Dupilumab-Associated Ocular Surface Disease in Patients with Atopic Dermatitis Is Frequent: A Nationwide Real-World Evidence StudyAne Marie Hovmand Nøhr, Pernille May Hansen, Michael Møller-Hansen, et al.
Acta Dermato-Venereologica|May 21, 2026
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 TrialsDiamant Thaçi, Luis Puig, Sei-Ichiro Motegi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2023
Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitisYael Renert-Yuval, Ester Del Duca, Bernd Arents, et al.
Skin Health and Disease|October 2, 2025
Harmonizing epidemiological research methodology for atopic dermatitis research: protocol for the EPISTAR international consensus exerciseSuzanne H Keddie, Karl Philipp Drewitz, Katrina Abuabara, et al.
BMJ Open|July 11, 2025
European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocolMatthias Augustin, Anthony Bewley, Marie-Charlotte Brüggen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 4, 2022
Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severityNita Katarina Frifelt Wienholtz, Jacob P Thyssen, Casper Emil Christensen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2022
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry TaskforceAngela L Bosma, Annelie H Musters, Manja Bloem, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Trials|March 1, 2017
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registriesLouise A A Gerbens, Aaron E Boyce, Dmitri Wall, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 6, 2023
A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head-and-neck dermatitisIda Vittrup, Niels Steen Krogh, Henrik Hedegaard Pliess Larsen, et al.
Acta Dermato-Venereologica|September 14, 2020
Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi ProcessJacob P Thyssen, Steffen Heegaard, Lena Ivert, et al.
Dermatology (Basel, Switzerland)|September 13, 2025
Dupilumab-Associated Ocular Surface Disease in Patients with Atopic Dermatitis Is Frequent: A Nationwide Real-World Evidence StudyAne Marie Hovmand Nøhr, Pernille May Hansen, Michael Møller-Hansen, et al.
Acta Dermato-Venereologica|May 21, 2026
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 TrialsDiamant Thaçi, Luis Puig, Sei-Ichiro Motegi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2023
Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitisYael Renert-Yuval, Ester Del Duca, Bernd Arents, et al.
Skin Health and Disease|October 2, 2025
Harmonizing epidemiological research methodology for atopic dermatitis research: protocol for the EPISTAR international consensus exerciseSuzanne H Keddie, Karl Philipp Drewitz, Katrina Abuabara, et al.
BMJ Open|July 11, 2025
European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocolMatthias Augustin, Anthony Bewley, Marie-Charlotte Brüggen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 4, 2022
Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severityNita Katarina Frifelt Wienholtz, Jacob P Thyssen, Casper Emil Christensen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2022
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry TaskforceAngela L Bosma, Annelie H Musters, Manja Bloem, et al.
Pageof 16